» Articles » PMID: 16598395

Increased Cardiac MRNA Expression of Matrix Metalloproteinase-1 (MMP-1) and Its Inhibitor (TIMP-1) in DCM Patients

Overview
Date 2006 Apr 7
PMID 16598395
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Left ventricular dilation and myocardial remodeling are hallmarks of dilated cardiomyopathy (DCM). It is assumed that left ventricular dilation is caused by the disintegration of the collagenous network by increased collagenolytic activity of matrix metalloproteinases (MMPs) and their adequate tissue inhibitors (TIMPs). In this study the myocardial MMP-1 and TIMP-1 mRNA expressions were investigated by using real-time quantitative PCR analysis from right septal endomyocardial biopsies of patients with dilated cardiomyopathy (n = 46) and control subjects (n = 11). The volume density (Vv%) of collagen was measured morphometrically. Classification was done according to LV diameters [left ventricular enddiastolic diameter (LVEDD, cm) calculated to body surface area (BSA, m(2))] into three DCM groups: group I (LVEDD-BSA > 2.7-3.0 cm/m(2)), group II ( > 3.0-3.6 cm/m(2)), group III ( > 3.6 cm/m(2)), controls (< 2.7 cm/m(2)). Compared with controls, the MMP-1 expression in patients with DCM was significantly increased (119.2 +/- 45.2 vs. 1.3 +/- 0.4; p < 0.001) as was TIMP-1 expression (9.6 +/- 1.2 vs. 1.3 +/- 0.4; p < 0.01). Moreover the MMP-1 and TIMP-1 expression varied according to LV diameter: group I (MMP-1: 8.7 +/- 3.5; p = 0.33; TIMP- 1: 4.5 +/- 1.2; p < 0.01); group II (MMP-1: 211.4 +/- 86.0; p < 0.001; TIMP-1: 12.5 +/- 1.9 ; p < 0.001); group III (MMP-1: 38.8 +/- 22.6; p < 0.01; TIMP-1: 8.1 +/- 1.7; p < 0.001). Compared with controls, the collagen level in DCMPt. was significantly increased: 5.0 +/- 0.6 vol% vs 1.2 +/- 0.2 vol% p < 0.001 and correlates with LV diameter. This study reveals that the overexpression of MMP-1, which is associated with an increased ratio of MMP-1/TIMP-1 in DCM, indicates an activated collagenolytic system while replacement fibrosis is accumulating. The MMP-1 overexpression is mainly found in moderately dilated DCM hearts (group II) indicating the dynamic process of LV dilation and the importance of collagenases in the early phase of LV remodeling.

Citing Articles

Prognostic Value of Circulating Fibrosis Biomarkers in Dilated Cardiomyopathy (DCM): Insights into Clinical Outcomes.

Kayvanpour E, Sedaghat-Hamedani F, Li D, Miersch T, Weis T, Hoefer I Biomolecules. 2024; 14(9).

PMID: 39334904 PMC: 11430616. DOI: 10.3390/biom14091137.


Progerinin, an Inhibitor of Progerin, Alleviates Cardiac Abnormalities in a Model Mouse of Hutchinson-Gilford Progeria Syndrome.

Kang S, Seo S, Song E, Kweon O, Jo A, Park S Cells. 2023; 12(9).

PMID: 37174632 PMC: 10177486. DOI: 10.3390/cells12091232.


Changes in Serum Levels of Matrix Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinases-1 in Patients with Essential Hypertension.

Kostov K, Blazhev A Bioengineering (Basel). 2022; 9(3).

PMID: 35324807 PMC: 8945798. DOI: 10.3390/bioengineering9030119.


Relationship of polymorphisms in the tissue inhibitor of metalloproteinase (TIMP)-1 and -2 genes with chronic heart failure.

Polina E, Araujo R, Sbruzzi R, Biolo A, Rohde L, Clausell N Sci Rep. 2018; 8(1):9446.

PMID: 29930267 PMC: 6013444. DOI: 10.1038/s41598-018-27857-5.


Inhibitor of lysyl oxidase improves cardiac function and the collagen/MMP profile in response to volume overload.

El Hajj E, El Hajj M, Ninh V, Gardner J Am J Physiol Heart Circ Physiol. 2018; 315(3):H463-H473.

PMID: 29775412 PMC: 6172641. DOI: 10.1152/ajpheart.00086.2018.


References
1.
Maquart F, Bellon G, Pasco S, Monboisse J . Matrikines in the regulation of extracellular matrix degradation. Biochimie. 2005; 87(3-4):353-60. DOI: 10.1016/j.biochi.2004.10.006. View

2.
Kuhl U, Noutsias M, Seeberg B, Schultheiss H . Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart. 1996; 75(3):295-300. PMC: 484290. DOI: 10.1136/hrt.75.3.295. View

3.
Spinale F, Coker M, Heung L, Bond B, Gunasinghe H, Etoh T . A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation. 2000; 102(16):1944-9. DOI: 10.1161/01.cir.102.16.1944. View

4.
Ratajska A, Cleutjens J . Embryogenesis of the rat heart: the expression of collagenases. Basic Res Cardiol. 2002; 97(3):189-97. DOI: 10.1007/s003950200011. View

5.
Nurnberg J, Butter C, Abdul-Khaliq H, Schlegl M, Lange P . Successful cardiac resynchronization therapy in a 9-year-old boy with dilated cardiomyopathy. Z Kardiol. 2005; 94(1):44-8. DOI: 10.1007/s00392-005-0168-7. View